|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 11 June 2008
doi: 10.1242/dev.022707
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Ecole Polytechnique Fédérale de Lausanne (EPFL), ISREC-Swiss
Institute for Experimental Cancer Research, School of Life Science, 1066
Epalinges, Switzerland.
2 Pacific Vascular Research Laboratory, Division of Vascular Surgery, Department
of Surgery, University of California, San Francisco, CA 94143, USA.
3 Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt
Drive, Oxford OX3 7BN, UK.
Author for correspondence (e-mail:
andreas.trumpp{at}epfl.ch)
Accepted 29 April 2008
The c-Myc protein has been implicated in playing a pivotal role in regulating the expression of a large number of genes involved in many aspects of cellular function. Consistent with this view, embryos lacking the c-myc gene exhibit severe developmental defects and die before midgestation. Here, we show that Sox2Cre-mediated deletion of the conditional c-mycflox allele specifically in the epiblast (hence trophoectoderm and primitive endoderm structures are wild type) rescues the majority of developmental abnormalities previously characterized in c-myc knockout embryos, indicating that they are secondary defects and arise as a result of placental insufficiency. Epiblast-restricted c-Myc-null embryos appear morphologically normal and do not exhibit any obvious proliferation defects. Nonetheless, these embryos are severely anemic and die before E12. c-Myc-deficient embryos exhibit fetal liver hypoplasia, apoptosis of erythrocyte precursors and functionally defective definitive hematopoietic stem/progenitor cells. Specific deletion of c-mycflox in hemogenic or hepatocytic lineages validate the hematopoietic-specific requirement of c-Myc in the embryo proper and provide in vivo evidence to support a synergism between hematopoietic and liver development. Our results reveal for the first time that physiological levels of c-Myc are essential for cell survival and demonstrate that, in contrast to most other embryonic lineages, erythroblasts and hematopoietic stem/progenitor cells are particularly dependent on c-Myc function.
Key words: c-Myc, Hematopoietic stem cell, Placenta, Embryonic hematopoiesis, Fetal liver, Survival, Mouse
Related articles in Development:
This article has been cited by other articles:
![]() |
M. Eilers and R. N. Eisenman Myc's broad reach Genes & Dev., October 15, 2008; 22(20): 2755 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo Development, July 15, 2008; 135(14): 2467 - 2477. [Abstract] [Full Text] [PDF] |
||||